allopurinol and Osteoporosis

allopurinol has been researched along with Osteoporosis* in 4 studies

Reviews

1 review(s) available for allopurinol and Osteoporosis

ArticleYear
Late medical complications of renal transplantation.
    Archives of internal medicine, 1969, Volume: 123, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Allopurinol; Autoimmune Diseases; Azathioprine; Bone Diseases; Diabetes Mellitus; Drug Synergism; Duodenal Ulcer; Embolism, Fat; Glomerulonephritis; Histocompatibility; Humans; Hypertension, Renal; Immunosuppressive Agents; Infections; Kidney Glomerulus; Kidney Transplantation; Malabsorption Syndromes; Male; Mercaptopurine; Neoplasm Transplantation; Neoplasms; Obesity; Osteoporosis; Pancreatitis; Peptic Ulcer Hemorrhage; Phenylbutazone; Postoperative Complications; Proteinuria; Transplantation, Homologous

1969

Other Studies

3 other study(ies) available for allopurinol and Osteoporosis

ArticleYear
Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Hei
    Heart (British Cardiac Society), 2012, Volume: 98, Issue:12

    It has been suggested that a higher calcium intake might favourably modify cardiovascular risk factors. However, findings of an ultimately decreased risk of cardiovascular disease (CVD) are limited. Instead, recent evidence warns that taking calcium supplements might increase myocardial infarction (MI) risk.. To prospectively evaluate the associations of dietary calcium intake and calcium supplementation with MI and stroke risk and overall CVD mortality.. Data from 23 980 Heidelberg cohort participants of the European Prospective Investigation into Cancer and Nutrition study, aged 35-64 years and free of major CVD events at recruitment, were analysed. Multivariate Cox regression models were used to estimate HRs and 95% CIs.. After an average follow-up time of 11 years, 354 MI and 260 stroke cases and 267 CVD deaths were documented. Compared with the lowest quartile, the third quartile of total dietary and dairy calcium intake had a significantly reduced MI risk, with a HR of 0.69 (95% CI 0.50 to 0.94) and 0.68 (95% CI 0.50 to 0.93), respectively. Associations for stroke risk and CVD mortality were overall null. In comparison with non-users of any supplements, users of calcium supplements had a statistically significantly increased MI risk (HR=1.86; 95% CI 1.17 to 2.96), which was more pronounced for calcium supplement only users (HR=2.39; 95% CI 1.12 to 5.12).. Increasing calcium intake from diet might not confer significant cardiovascular benefits, while calcium supplements, which might raise MI risk, should be taken with caution.

    Topics: Adult; Allopurinol; Calcium; Calcium, Dietary; Dietary Supplements; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Nutrition Surveys; Osteoporosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Stroke; Survival Rate

2012
Type 1 glycogen storage disease and recurrent calcium nephrolithiasis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16, Issue:6

    Topics: Absorptiometry, Photon; Adolescent; Allopurinol; Amiloride; Calcinosis; Diet, Sodium-Restricted; Diuretics; Drug Therapy, Combination; Glycogen Storage Disease Type I; Gout Suppressants; Humans; Hydrochlorothiazide; Kidney Calculi; Male; Osteoporosis; Recurrence

2001
[Gout in the evolution of Von Gierke's disease].
    Minerva medica, 1969, May-12, Volume: 60, Issue:38

    Topics: Adolescent; Adult; Allopurinol; Child; Female; Glycogen Storage Disease; Glycogen Storage Disease Type I; Gout; Hepatomegaly; Humans; Hyperlipidemias; Joint Diseases; Lactates; Male; Middle Aged; Osteoporosis; Purines; Uric Acid; Uricosuric Agents

1969